J. Andrew Livingston, M.D., M.S.

Peer-Reviewed Articles

1. Roth ME, Griffith W, Choi E, Yarbrough A, Bell D, Adams L, Corredor J, DeRousse H, Harris J, Blanc J, Parker C, Guzman D, Robinson M, Chernyshov A, Cheng J, Saldana A, Mistry H, Livingston JA. Development of a Multidisciplinary Adolescent and Young Adult Program at a Large Academic Cancer Center. JCO Oncol Pract:OP2500665, 2026. e-Pub 2026. PMID: 41616235.
2. Arifin AJ, Bishop AJ, Mitra D, Yoder A, Araujo DM, Haddad EFN, Ratan R, Livingston JA, Lewis VO, Lin PP, Moon BS, Keung EZ, Roland CL, Scally CP, Mericli AF, Guadagnolo BA, Farooqi AS. Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue Sarcoma. Pract Radiat Oncol, 2026. e-Pub 2026. PMID: 41579133.
3. Patel BA, Smith JT, Wangsiricharoen S, Wang WL, Lin PP, Farooqi A, Nassif Haddad EF, Ummed K, Mericli AF, Adelman DM, Livingston JA, Conley AP. Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone. Front Oncol 16:1645629, 2026. e-Pub 2026. PMID: 41768232.
4. Patel RR, Feit J, Werling G, White NM, Bishop AJ, Lin PP, Valenzuela Perez RF, Lazar AJ, Benjamin RS, Patel SR, Ludwig J, Ravi V, Livingston JA, Zarzour MA, Conley A, Somaiah N, Araujo DM. Primary Synovial Sarcoma of the Abdomen and Pelvis. Am J Clin Oncol, 2025. e-Pub 2025. PMID: 41342607.
5. Berkman A, Roth M, Livingston JA. Metastatic Recurrence in Adolescent and Young Adult Cancer-Key Drivers of Early Mortality. JAMA Oncol, 2025. e-Pub 2025. PMID: 41296340.
6. Choi E, Berkman AM, Andersen CR, Salsman JM, Betts AC, Milam J, Miller KA, Peterson SK, Lu Q, Cheung CK, Ghazal LV, Livingston JA, Hildebrandt MAT, Parsons SK, Freyer DR, Roth ME. Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult Cancer. J Adolesc Young Adult Oncol, 2025. e-Pub 2025. PMID: 40712648.
7. Traweek, R, Zoghbi, M, Segura Lazcano, R, Cope, B, Bishop, AJ, Farooqi, AS, Mitra, D, Yoder, A, Guadagnolo, BA, Ingram, D, Wani, K, Shamsutdinova, D, Lazar, A, Wang, W, Scally, CP, Keung, EZ, Torres, KE, Hunt, KK, Ratan, R, Livingston, JA, Nakazawa, MS, Araujo, DM, Patel, S, Ravi, V, Conley, AP, Zarzour, MA, Somaiah, N, Roland, CL, Nassif, EF. Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma. ESMO Open 10(7), 2025. e-Pub 2025. PMID: 40561658.
8. Berkman AM, Andersen CR, Puthenpura V, Short NJ, Merriman K, Swaminathan M, Cuglievan B, McCall D, DiNardo C, Nunez C, Jain N, Kadia T, Issa G, Gibson A, Garcia MB, Livingston JA, Parsons S, Hildebrandt MAT, Roth ME. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectr 9(4), 2025. e-Pub 2025. PMID: 40579211.
9. Berkman AM, Andersen CR, Dixon SB, Ramirez A, Gilmore K, Thoman W, Razouki ZA, Santos D, Thosani S, Livingston JA, Hildebrandt MAT, Roth ME. Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. J Adolesc Young Adult Oncol, 2025. e-Pub 2025. PMID: 40452567.
10. Cruz CA, Rodriguez ER, Thawani M, Mazer M, Hayhurst M, Swanson M, Romero A, Livingston JA, Aune G, Eshelman-Kent D, Cuglievan B, Roth ME, Ahmed S, Albritton K, Hildebrandt MAT. Differences in time to treatment and impact on overall survival in adolescents and young adults with Hodgkin lymphoma. Leuk Lymphoma:1-7, 2025. e-Pub 2025. PMID: 40337837.
11. Ginn MP, Denu RA, Ingram DR, Wani KM, Lazar AJ, Harrison DJ, Nakazawa MS, Conley AP, Patel S, Livingston JA. TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature. Cancers (Basel) 17(9), 2025. e-Pub 2025. PMID: 40361368.
12. Livingston JA, Blay JY, Trent J, Valverde C, Agulnik M, Gounder M, Le Cesne A, McKean M, Wagner MJ, Stacchiotti S, Agresta S, Quintas-Cardama A, Reilly SA, Healy K, Hickman D, Zhao T, Ballesteros-Perez A, Khalil A, Collins MP, Piel J, Horrigan K, Lefkovith A, Innis S, Lazar AJ, Cote GM, Wagner AJ. A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors. Clin Cancer Res 31(4):628-638, 2025. e-Pub 2025. PMID: 39660994.
13. Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, A, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
14. Roth, M, Andersen, C, Berkman, AM, Siegel, SE, Cuglievan, B, Livingston, JA, Hildebrandt, MA, Estrada, J, Bleyer, A. Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion. Cancer 131(1), 2025. e-Pub 2025. PMID: 39370757.
15. Patel, R, Delclos, GL, Desantis, SM, Cannell, MB, Lupo, PJ, Bishop, AJ, Lazar, A, Lin, PP, Benjamin, RS, Patel, S, Ludwig, JA, Ravi, V, Livingston, JA, Somaiah, N, Alejandra Zarzour, M, Conley, AP, Araujo, DM. Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. American Journal of Clinical Oncology: Cancer Clinical Trials 48(1):21-27, 2025. e-Pub 2025. PMID: 39224003.
16. Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Battle A, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Black adolescent and young adult cancer survivors. J Cancer Surviv 18(6):1931-1940, 2024. e-Pub 2023. PMID: 37578615.
17. Choi, E, Berkman, AM, Andersen, C, Salsman, JM, Betts, AC, Milam, J, Miller, KA, Peterson, SK, Lu, Q, Cheung, CK, Ghazal, L, Livingston, JA, Hildebrandt, MA, Parsons, SK, Freyer, DR, Roth, M. Psychological distress and mental health care utilization among lesbian, gay, and bisexual survivors of adolescent and young adult cancer. Supportive Care in Cancer 32(9), 2024. e-Pub 2024. PMID: 39134915.
18. Yoder, AK, Farooqi, AS, Mitra, D, Livingston, JA, Araujo, DM, Sturgis, EM, Goepfert, RP, Bishop, AJ, Guadagnolo, BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Practical radiation oncology 14(5):e373-e382, 2024. e-Pub 2024. PMID: 38851534.
19. Choi, E, Berkman, AM, Battle, A, Betts, AC, Salsman, JM, Milam, J, Andersen, C, Miller, KA, Peterson, SK, Lu, Q, Cheung, CK, Livingston, JA, Hildebrandt, MA, Parsons, SK, Freyer, DR, Roth, M. Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancer. Cancer 130(17):3011-3022, 2024. e-Pub 2024. PMID: 38676935.
20. Stafford, LK, Tang, X, Brandt, AC, Ma, J, Banchs, J, Livingston, JA, Roth, M, Morrison, AC, Hildebrandt, MA. Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors. Pharmacogenomics Journal 24(4), 2024. e-Pub 2024. PMID: 38951505.
21. George, GC, Andersen, C, Tang, X, Rodriguez, ER, Jafry, MZ, Swartz, MC, Ahmed, S, Barcenas, CH, Livingston, JA, Roth, M, Hildebrandt, MA. Patient-Reported Quality of Life at Diagnosis in Adolescent and Young Adults With Cancer. JNCCN Journal of the National Comprehensive Cancer Network 22(6), 2024. e-Pub 2024. PMID: 38996438.
22. Rodriguez, ER, Tonn, T, Jafry, MZ, Ahmed, S, Cuglievan, B, Livingston, JA, Flowers, CR, Aune, GJ, Albritton, KH, Roth, M, Xiao, Q, Hildebrandt, MA. Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival. JNCI Cancer Spectrum 8(4), 2024. e-Pub 2024. PMID: 39051679.
23. Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther 23(7):1057-1065, 2024. e-Pub 2024. PMID: 38561019.
24. Nasr, L, Zoghbi, M, Segura Lazcano, R, Nakazawa, MS, Bishop, AJ, Farooqi, AS, Mitra, D, Guadagnolo, BA, Benjamin, RS, Patel, S, Ravi, V, Araujo, DM, Livingston, JA, Zarzour, MA, Conley, AP, Ratan, R, Somaiah, N, Lazar, A, Roland, CL, Keung, EZ, Nassif, EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade. Cancers 16(9), 2024. e-Pub 2024. PMID: 38730715.
25. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
26. Thirasastr, P, Sutton, TL, Joseph, CP, Lin, Y, Amini, B, Mayo, SC, Araujo, DM, Benjamin, RS, Conley, AP, Livingston, JA, Ludwig, JA, Patel, S, Ratan, R, Ravi, V, Zarzour, MA, Nassif Haddad, EF, Nakazawa, MS, Zhou, X, Heinrich, MC, Somaiah, N. Outcomes of Late-Line Systemic Treatment in GIST. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473266.
27. Berkman, AM, Choi, E, Cheung, CK, Salsman, JM, Peterson, SK, Andersen, C, Lu, Q, Livingston, JA, Hildebrandt, MA, Parsons, SK, Roth, M. Risk of chronic health conditions in lesbian, gay, and bisexual survivors of adolescent and young adult cancers. Cancer 130(4):553-562, 2024. e-Pub 2024. PMID: 38044705.
28. Nakazawa, MS, Livingston, JA, Zarzour, MA, Bishop, AJ, Ratan, R, Ludwig, JA, Araujo, DM, Somaiah, N, Ravi, V, Nassif, EF, Roland, CL, Lazar, A, Guadagnolo, BA, Harrison, DJ, Benjamin, RS, Patel, S, Conley, AP. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies. Rare Tumors 16, 2024. e-Pub 2024. PMID: 39105190.
29. Cho, D, Roth, M, Peterson, SK, Jennings, K, Kim, S, Weathers, S, Ahmed, S, Livingston, JA, Barcenas, CH, You, YN, Milbury, K. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship. JMIR Research Protocols 13(1), 2024. e-Pub 2024. PMID: 38652520.
30. Choi, E, Berkman, AM, Cheung, CK, Betts, AC, Salsman, JM, Andersen, C, Ochoa-Dominguez, CY, Miller, KA, Milam, J, Shah, A, Peterson, SK, Lu, Q, Livingston, JA, Hildebrandt, MA, Parsons, SK, Freyer, DR, Roth, M. Psychological distress and mental health care utilization among Hispanic/Latino survivors of adolescent and young adult cancer. Psycho-oncology 32(12):1918-1929, 2023. e-Pub 2023. PMID: 37955581.
31. Wooten, SV, Wang, F, Roth, M, Liu, G, Livingston, JA, Amini, B, Gilchrist, SC, Hildebrandt, MA, Kleinerman, ES. Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. Cancer medicine 12(22):20798-20809, 2023. e-Pub 2023. PMID: 37902220.
32. Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis VO, Roszik J, Livingston JA, Wang WL, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza SM, Akdemir KC, Rodon Ahnert J, Subbiah V, Patel S, Conley AP. Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clin Cancer Res. e-Pub 2023. PMID: 37747813.
33. Jeyabal P, Bhagat A, Wang F, Roth M, Livingston JA, Gilchrist SC, Banchs J, Hildebrandt MAT, Chandra J, Deswal A, Koutroumpakis E, Wang J, Daw NC, Honey TA, Kleinerman ES. Circulating microRNAs and cytokines as prognostic biomarkers for doxorubicin-induced cardiac injury and for evaluating the effectiveness of an exercise intervention. Clin Cancer Res. e-Pub 2023. PMID: 37651264.
34. Berkman AM, Choi E, Cheung CK, Salsman JM, Peterson SK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Socioeconomic Status and Chronic Health Conditions in Asian Survivors of Adolescent and Young Adult Cancers. J Adolesc Young Adult Oncol. e-Pub 2023. PMID: 37594775.
35. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Parsons SK, Roth M. Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer. JCO Oncol Pract 19(8):610-619, 2023. e-Pub 2023. PMID: 37311165.
36. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21(8):851-880, 2023. e-Pub 2023. PMID: 37549914.
37. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Roth M. Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy. Cancer Med 12(13):14157-14170, 2023. e-Pub 2023. PMID: 37199075.
38. Truong DD, Lamhamedi-Cherradi SE, Porter RW, Krishnan S, Swaminathan J, Gibson A, Lazar AJ, Livingston JA, Gopalakrishnan V, Gordon N, Daw NC, Navin NE, Gorlick R, Ludwig JA. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer 23(1):488, 2023. e-Pub 2023. PMID: 37254069.
39. Wooten SV, Amini B, Livingston JA, Hildebrandt MAT, Chandra J, Gilchrist SC, Roth M, Kleinerman E. Poor Sit-to-Stand Performance in Adolescent and Young Adult Patients with Sarcoma. J Adolesc Young Adult Oncol. e-Pub 2023. PMID: 37155195.
40. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res 29(9):1708-1718, 2023. e-Pub 2023. PMID: 37058010.
41. Berkman AM, Andersen CR, Hildebrandt MAT, Livingston JA, Green AL, Puthenpura V, Peterson SK, Milam J, Miller KA, Freyer DR, Roth ME. Risk of early death in adolescents and young adults with cancer: a population-based study. J Natl Cancer Inst 115(4):447-455, 2023. e-Pub 2023. PMID: 36682385.
42. Berkman AM, Choi E, Salsman JM, Peterson SK, Cheung CK, Andersen CR, Lu Q, Livingston JA, Hildebrandt MAT, Parsons SK, Roth ME. Excess risk of chronic health conditions in Hispanic survivors of adolescent and young adult cancers. J Cancer Surviv. e-Pub 2023. PMID: 36750493.
43. Whiteway SL, Weiss AR, Ahmed SK, Allen-Rhoades WA, Avutu V, Cardona K, Davis LE, Davis EJ, Indelicato DJ, Isakoff MS, Janeway KA, Livingston JA, Patel SR, Reed DR, Riedel RF, Thornton KA, Kopp LM. Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group. J Adolesc Young Adult Oncol. e-Pub 2023. PMID: 36724495.
44. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2023. PMID: 36151848.
45. Beird, H, Bielack, S, Flanagan, AM, Gill, JB, Heymann, D, Janeway, K, Livingston, JA, Roberts, RD, Strauss, SJ, Gorlick, R. Osteosarcoma. Nature Reviews Disease Primers 8(1), 2022. e-Pub 2022. PMID: 36481668.
46. Moyers JT, Carmagnani Pestana R, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap T, Karp D, Rodon J, Livingston JA, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res. e-Pub 2022. PMID: 36288393.
47. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
48. D'Angelo SP, Richards AL, Conley AP, Woo HJ, Dickson MA, Gounder M, Kelly C, Keohan ML, Movva S, Thornton K, Rosenbaum E, Chi P, Nacev B, Chan JE, Slotkin EK, Kiesler H, Adamson T, Ling L, Rao P, Patel S, Livingston JA, Singer S, Agaram NP, Antonescu CR, Koff A, Erinjeri JP, Hwang S, Qin LX, Donoghue MTA, Tap WD. Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma. Nat Commun 13(1):3477, 2022. e-Pub 2022. PMID: 35710741.
49. Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. Nat Commun 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
50. Berkman AM, Andersen CR, Cuglievan B, McCall DC, Lupo PJ, Parsons SK, DiNardo CD, Short NJ, Jain N, Kadia TM, Livingston JA, Roth ME. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis. Cancer Epidemiol Biomarkers Prev 31(6):1176-1184, 2022. e-Pub 2022. PMID: 35553621.
51. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
52. Miller D, Livingston JA, Park Y, Posey K, Godbole S, Skubitz K, Robinson SI, Agulnik M, Davis LE, Van Tine BA, Hirbe AC, Parkes A. Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer Med. e-Pub 2022. PMID: 35343652.
53. Morand M, Roth M, Peterson SK, Bednar EM, Ramdaney A, Livingston JA, Yarbrough A, Corredor J. Factors impacting adolescent and young adult cancer patients' decision to pursue genetic counseling and testing. Support Care Cancer. e-Pub 2022. PMID: 35306607.
54. Roth, M, Berkman, AM, Andersen, C, Cuglievan, B, Livingston, JA, Hildebrandt, MA, Bleyer, A. Improved Survival of Young Adults with Cancer Following the Passage of the Affordable Care Act. Oncologist 27(2):135-143, 2022. e-Pub 2022. PMID: 35641206.
55. Wu CC, Wang YA, Livingston JA, Zhang J, Futreal PA. Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association. Nat Commun 13(1):42, 2022. e-Pub 2022. PMID: 35013211.
56. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
57. Lamhamedi-Cherradi SE, Mohiuddin S, Mishra DK, Krishnan S, Velasco AR, Vetter AM, Pence K, McCall D, Truong DD, Cuglievan B, Menegaz BA, Utama B, Daw NC, Molina ER, Zielinski RJ, Livingston JA, Gorlick R, Mikos AG, Kim MP, Ludwig JA. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer Gene Ther 28(12):1325-1338, 2021. e-Pub 2021. PMID: 33408328.
58. Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors. Cancer Epidemiol 75:102044, 2021. e-Pub 2021. PMID: 34597882.
59. Roszik J, Mustachio LM, Livingston JA, Groisberg R, Carmagnani Pestana R, Subbiah V, Conley AP. Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680396.
60. Berkman AM, Andersen CR, Puthenpura V, Livingston JA, Ahmed S, Cuglievan B, Hildebrandt MAT, Roth ME. Impact of race, ethnicity and socioeconomic status over time on the long-term survival of adolescent and young adult Hodgkin lymphoma survivors. Cancer Epidemiol Biomarkers Prev 30(9):1717-1725, 2021. e-Pub 2021. PMID: 34244160.
61. Wooten SV, Roth M, Livingston JA, Hildebrandt MAT, Chandra J, Amini B, Kleinerman ES, Gilchrist SC. Short-Term Changes in Skeletal Muscle Mass After Anthracycline Administration in Adolescent and Young Adult Sarcoma Patients. J Adolesc Young Adult Oncol. e-Pub 2021. PMID: 34388045.
62. Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys 110(5):1496-1504, 2021. e-Pub 2021. PMID: 33677051.
63. Makhnoon S, Corredor J, Arun B, Bell D, Yarbrough A, Livingston JA, Peterson SK, Roth M. Impact of a Genetic Evaluation Initiative to Increase Access to Genetic Services for Adolescent and Young Adults at a Tertiary Cancer Hospital. J Adolesc Young Adult Oncol 10(3):296-302, 2021. e-Pub 2021. PMID: 32830989.
64. Cuglievan B, Berkman A, Dibaj S, Wang J, Andersen CR, Livingston JA, Gill J, Bleyer A, Roth M. Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients. J Adolesc Young Adult Oncol 10(2):164-174, 2021. e-Pub 2021. PMID: 32678703.
65. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
66. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2021. PMID: 33289298.
67. Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA. Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma. Cell Rep 34(4):108678, 2021. e-Pub 2021. PMID: 33503424.
68. Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, ÉMC Á, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R, Avagliano L, Ávalos Y, Aveic S, Aveleira CA, Avin-Wittenberg T, Aydin Y, Ayton S, Ayyadevara S, Azzopardi M, Baba M, Backer JM, Backues SK, Bae DH, Bae ON, Bae SH, Baehrecke EH, Baek A, Baek SH, Baek SH, Bagetta G, Bagniewska-Zadworna A, Bai H, Bai J, Bai X, Bai Y, Bairagi N, Baksi S, Balbi T, Baldari CT, Balduini W, Ballabio A, Ballester M, Balazadeh S, Balzan R, Bandopadhyay R, Banerjee S, Banerjee S, Á B, Bao Y, Baptista MS, Baracca A, Barbati C, Bargiela A, Barilà D, Barlow PG, Barmada SJ, Barreiro E, Barreto GE, Bartek J, Bartel B, Bartolome A, Barve GR, Basagoudanavar SH, Bassham DC, Bast RC, Basu A, Batoko H, Batten I, Baulieu EE, Baumgarner BL, Bayry J, Beale R, Beau I, Beaumatin F, Bechara LRG, Beck GR, Beers MF, Begun J, Behrends C, Behrens GMN, Bei R, Bejarano E, Bel S, B. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy 17(1):1-382, 2021. e-Pub 2021. PMID: 33634751.
69. Dupuis M, Shen Y, Curcio C, Meis J, Wang W, Amini B, Rhines L, Livingston JA. Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor. Clinical Sarcoma Research, 2020. e-Pub 2020.
70. Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka D, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
71. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32630797.
72. Mull BB, Livingston JA, Patel N, Bui T, Hunt KK, Keyomarsi K. Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer. Br J Cancer 122(6):812-822, 2020. e-Pub 2020. PMID: 31942030.
73. Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun 11(1):1008, 2020. e-Pub 2020. PMID: 32081846.
74. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
75. Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy with both Radiation and Surgery Improves Local Control. Am J Clin Oncol 42(10):744-748, 2019. e-Pub 2019. PMID: 31436747.
76. Roszik J, Khan A, Conley AP, Livingston JA, Groisberg R, Ravi V, Carmagnani Pestana R, Sen S, Subbiah V. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets. Cancers (Basel) 11(9), 2019. e-Pub 2019. PMID: 31480474.
77. Zhao Q, Hu J, Mitra A, Cutrera J, Zhang W, Zhang Z, Yan J, Xia X, Mahadeo KM, Livingston JA, Gorlick R, Li S. Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile. J Immunother Cancer 7(1):154, 2019. e-Pub 2019. PMID: 31208461.
78. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31096717.
79. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol 42(3):238-242, 2019. e-Pub 2019. PMID: 30614820.
80. Gilchrist SC, Roth M, Livingston JA, Hildebrandt MAT, Kleinerman ES, Banchs J. Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines. J Adolesc Young Adult Oncol. e-Pub 2019. PMID: 30794081.
81. Avila JC, Livingston JA, Rodriguez AM, Kirchhoff AC, Kuo YF, Kaul S. Disparities in Adolescent and Young Adult Sarcoma Survival: Analyses of the Texas Cancer Registry and the National SEER Data. J Adolesc Young Adult Oncol 7(6):681-687, 2018. e-Pub 2018. PMID: 30096005.
82. Kaul S, Russell H, Livingston JA, Kirchhoff AC, Jupiter D. Emergency Department Visits by Adolescent and Young Adult Cancer Patients Compared with Pediatric Cancer Patients in the United States. J Adolesc Young Adult Oncol 7(5):553-564, 2018. e-Pub 2018. PMID: 29924663.
83. Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M, Gordon NB, Kleinerman ES. Analysis of HSP27 and the autophagy marker LC3B+ puncta following preoperative chemotherapy identifies high-risk osteosarcoma patients. Mol Cancer Ther 17(6):1315-1323, 2018. e-Pub 2018. PMID: 29592877.
84. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. e-Pub 2017. PMID: 28710342.
85. Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep 7(1):11836, 2017. e-Pub 2017. PMID: 28928422.
86. Santiago-O'Farrill JM, Kleinerman ES, Hollomon MG, Livingston A, Wang WL, Tsai JW, Gordon NB. Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy. Oncotarget 9(2):1602-1616, 2017. e-Pub 2017. PMID: 29416717.
87. McManus M, Kleinerman E, Yang Y, Livingston JA, Mortus J, Rivera R, Zweidler-McKay P, Schadler K. Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma. Pediatr Blood Cancer 64(5), 2017. e-Pub 2017. PMID: 27786411.
88. Livingston JA, Hess KR, Naing A, Hong DS, Patel S, Benjamin RS, Ludwig JA, Conley A, Herzog CE, Anderson P, Meric-Bernstam F, Kurzrock R, Subbiah V. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget 7(39):64421-64430, 2016. e-Pub 2016. PMID: 27486883.
89. Wagner MJ, Livingston JA, Patel SR, Benjamin RS. Chemotherapy for Bone Sarcoma in Adults. J Oncol Pract 12(3):208-16, 2016. e-Pub 2016. PMID: 26962160.
90. Subbiah V, Bupathi M, Kato S, Livingston, A, Slopis, J, Anderson, P, Hong, DS. Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients. Oncoscience. e-Pub 2015. PMID: 26328274.
91. Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Niedzwiecki D, Chao NJ, Horwitz ME. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(11):1664-1676.e1, 2012. e-Pub 2012. PMID: 22698485.

Invited Articles

1. El Beaino M, Roszik J, Livingston JA, Wang WL, Lazar AJ, Amini B, Subbiah V, Lewis V, Conley AP. Mesenchymal chondrosarcoma: A review with emphasis on its fusion-driven biology. Curr Oncol Rep 20(5):37, 2018. e-Pub 2018. PMID: 29582189.
2. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res 7:11, 2017. e-Pub 2017. PMID: 28630682.

Review Articles

1. Propst, CL, Sucholeiki, RL, Chandra, J, Livingston, JA, Roth, M, Hong, DS, George, GC. Diet in adolescent and young adult patients with cancer and cancer survivors. Supportive Care in Cancer 33(6), 2025. e-Pub 2025. PMID: 40411574.
2. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Andring LM, Geng Y, Kouzy R, Livingston JA, Peterson SK, Bishop AJ, Smith GL, Gunther JR, Parsons SK, Roth M. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review. Support Care Cancer 31(4):230, 2023. e-Pub 2023. PMID: 36961516.
3. Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. Chemotherapy for bone sarcomas in adults: the MD anderson experience. Am Soc Clin Oncol Educ Book:e656-60, 2015. e-Pub 2015. PMID: 25993237.
4. Lamhamedi-Cherradi SE, Santoro M, Ramammoorthy V, Menegaz BA, Bartholomeusz G, Iles LR, Amin HM, Livingston JA, Mikos AG, Ludwig JA. 3D tissue-engineered model of Ewing's sarcoma. Adv Drug Deliv Rev 79-80:155-71, 2014. e-Pub 2014. PMID: 25109853.

Other Articles

1. Beird, H, Bielack, S, Flanagan, AM, Gill, JB, Heymann, D, Janeway, K, Livingston, JA, Roberts, RD, Strauss, SJ, Gorlick, R Author Correction. Nature Reviews Disease Primers 8(1), 2022. PMID: 36585406.
2. Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(1):66-97, 2018. PMID: 29295883.

Editorials

1. Livingston JA. Improving Outcomes for Adolescents and Young Adults With Sarcoma: A Focus on Cancer Care Delivery. J Oncol Pract 15(5):253-254, 2019. PMID: 31075216.

Abstracts

1. J Andrew Livingston J. Preliminary results from a Phase 1 study of FHD-609, a bromodomain-containing protein 9 degrader, in patients with advanced synovial sarcoma or SMARCB1-loss tumors. CTOS 2023 Annual Meeting, Oral Presentation(1571413), 2023. e-Pub 2023.
2. Nakazawa M, Wang WL, et al LJ. RNASe H@ loss identifies a unique subset of DDR deficient Leiomyosarcoma. ASCO Annual Meeting, 2023. e-Pub 2023.
3. Truong DD, Lamhamedi-Cherradi S, Maitituoheti M, Beird H, Wu C, Krishnan S, Ingram DR, McCall D, Cuglievan B, P Andrew Futreal P, Titus M, Lazar A, Wang W, Rai K, A Robert MacLeod A, Ratan R, J Andrew Livingston J, Daw NC, Hayes-Jordan A, Ludwig JA. The Epigenetic Impact and Therapeutic Opportunity of AR-Directed Therapy for DSRCT. CTOS 2022 Annual Meeting, 2022. e-Pub 2022.
4. Gill J, Conley AP, Somaiah N, Araujo DM, Ratan R, Posey K, Benjamin RS, Patel S, Daw NC, Harrison DJ, Gorlick R, Lin H, Wang W, Amini B, Gordon N, J Andrew Livingston J. A Phase 1/2 Trial of Gemcitabine, Docetaxel, and Hydroxychloroquine in Advanced / Metastatic Osteosarcoma: Results of Phase 1. CTOS 2022 Annual Meeting, 2022. e-Pub 2022.
5. Conley AP, Li L, Livingston JA, Bishop AJ, Grosshanes D, Ghia A, Mathew G, Khanduri I, Lang W, Bird J, Alvarez-Breckenridge C, Raza SM, Rhines LD, DeMonte F, Lazar A, Wang WL, Aarve A, Lin H, Roszik J, Amini B, Yevich S, Levy J, Sommer J, Freed D, Akdemir KC, Pudevali V, Patel SR. A Phase 2 Trial of Cetuximab for Patients with Locally Advanced Metastatic Chordoma. 2. 2022 CTOS Annual Meeting, 2022. e-Pub 2022.
6. Corrigan K, Smith G, Lee K, Afridi F, Andring L, Swartz M, Bishop A, Hoffman K, Livingston J, Peterson S, Roth M. Patient-Reported Quality of Life in Adolescents and Young Adults with Cancer Before, During, and After Radiation Therapy. ASTRO Annual Meeting, 2022. e-Pub 2022.
7. Farooqi A, Yoder A, Pasalic D, Erasmus J, Wernz C, Mitra D, Somaiah N, Conley A, Ratan R, Livingston J, Roland C, Scally C, Keung E, Gandhi S, B Ashleigh Guadagnolo B, Nguyen Q, Bishop A. Stereotactic ablative radiation therapy for sarcoma lung metastases: indications for treatment and patterns of failure. ASTRO Annual Meeting, 2022. e-Pub 2022.
8. Avutu V, Slotkin EK, J Andrew Andrew Livingston J, Chawla SP, Pressey JG, Nandkumar P, Zheng C, Misir S, Pultar P, Voliotis D, Thornton KA, Federman N. A phase 1/2 dose-escalation and dose-expansion study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma. ASCO Annual Meeting, 2022. e-Pub 2022.
9. Somaiah N, J Andrew Andrew Livingston J, Ravi V, Lin HY, Amini B, Solis LM, Conley AP, Zarzour MA, Ludwig JA, Ratan R, Wang W, Araujo DM, Patel S, Roland CL, Lazar AJ, Gorlick RG, Parra ER, Haymaker CL. A phase II multi-arm study to test the efficacy of oleclumab and durvalumab in specific sarcoma subtypes. ASCO Annual Meeting, 2022. e-Pub 2022.
10. Parkes A, Posey K, Robinson, Van Tine B, Livingston JA. OUTCOMES RELATED TO THE TREATMENT OF SARCOMAS WITH ANTHRACYCLINES AND/OR IFOSFAMIDE DURING PREGNANCY. CTOS Annual Meeting, 2021. e-Pub 2021.
11. Forest S, Kinnaman M, Livingston JA, Vo K, Merriam P, Clinton C, Desmith K, Sweet-Cordero A, Janeway K. Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma. ASCO Annual Meeting, 2021. e-Pub 2021.
12. Gordon N, Kleinerman E, Sheshdari A, Blanco D, Yedururi S, Morani A, Gill J, Harrison D, Herzog C, Livingston JA, Benjamin R, Gorlick R, Mireles M, Kawedia J, Daw N. A phase I trial of aerosol gemcitabine for the treatment of patients with solid tumors and lung metastases. ASCO Annual Meetgin, 2020. e-Pub 2020.
13. Somaiah N, Conley AP, Lin H, Amini B, Sabir S, Araujo D, Benjamin R, Livingston JA, Patel S, Ratan R, Ravi V, Zarzour M, Wang W, Tate T, Roland C, Daw N, Futreal A, Lazar A, Wistuba I, Hwu P. A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas. ASCO Annual Meeting, 2020. e-Pub 2020.
14. McCall D, Roszik J, Cuglievan B, Ludwig J, Zarzour M, Gill J, Livingston JA, Subbiah V. EWS-Fusion Partners in Sarcoma as Revealed by "Real World" Genomic Sequencing: Clinical Implications. CTOS Annual Meeting, 2019. e-Pub 2019.
15. Wang WL, Lazar A, Wu CC, Beird H, Ingram D, Khan S, Wani K, Daw N, Futreal A, Livingston JA. DNA Damage Response Deficiency in Osteosarcoma. CTOS Annual Meeting, 2019. e-Pub 2019.
16. D'Angelo S, Conley A, Kelly C, Dickson M, Gounder M, Chi P, Livingston JA, Patel S, Adamson T, Kiesler H, Hwang S, Tap W. Pilot study of NKTR214 and nivolumab in patients with sarcomas. ASCO Annual Meeting, 2019. e-Pub 2019.
17. Amaria R, Bernatchez C, Forget MA, Haymaker C, Conley A, Livingston JA, Varadachary G, Java M, Mitra A, Tzeng C, Hinchiff E, Bayer V, Hilton T, Celestiino J, Rangel K, Yuan Y, Lu K, Hwu P, Jazaeri A. Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers. ASCO Annual Meeting, 2019. e-Pub 2019.
18. Livingston JA, Posey K, et al WW. Chemotherapy in the treatment of undifferentiated high grade pleomorphic sarcoma of bone. CTOS Annual Meeting, 2018. e-Pub 2018.
19. Livingston JA, Beird HC, Wu C, Cao, Advani, Ingram, Wang WL, Lazar AJ, Leung, Lin, Reuben, Roszik, Wang W, Patel S, Benjamin R, Gorlick R, Lewis V, Futreal PA, Daw N. Parallel genomic and immune profiling of relapsed and metastatic osteosarcoma to reveal bases of low immunogenicity. ASCO Annual Meeting, 2018. e-Pub 2018.
20. Wu C, Beird HC, Livingston JA, Cao, Advani, Ingram, Wang WL, Lazar AJ, Leung, Lin, Reuben, Roszik, Wang W, Patel S, Benjamin R, Gorlick R, Lewis V, Daw N, Futreal PA. Genome and transcriptome profiling of relapsed and metastatic osteosarcoma. ASCO Annual Meeting, 2018. e-Pub 2018.
21. Livingston JA, Posey K, Subbiah VS, Daw N, Somaiah N, Ravi V, Patel S, Benjamin RS, Wang WL, Lazar AJ, Broaddus R, Meric-Bernstam F, Shaw K, Roszik J, Conley AP. Analysis of osteosarcoma subtypes by clinical genomic testing to identify clinically actionable alterations. ASCO Annual Meeting, 2017. e-Pub 2017.
22. Avila JC, Livingston JA, Rodriguez A, Kirchoff AC, Kue TF, Kaul S. Disparities in Survival Among Adolescent and Young Adult Patients with Sarcomas in Texas. AACR Annual Meeting 2017, 2017. e-Pub 2017.
23. Subbiah V, Conley A, Livingston JA, Lazar A, Meric-Bernstam F, Futreal A, Roszik J. Picking Antibody-drug conjugate targets for drug development for sarcoma: Diving deeper into TCGA. CTOS Annual Meeting, 2017. e-Pub 2017.
24. Ratan R, et al LJ. CIC rearranged sarcomas. CTOS Annual Meeting, 2017. e-Pub 2017.
25. Roszik J, Conley AP, Livingston JA, Ravi V, Lazar A. Next-generation sequencing identifies immunotherapy targets in soft tissue sarcoma. Connective Tissue Oncology Society Annual Meeting, 2017. e-Pub 2017.
26. Conley AP, et al LJ. Assessment of next-generation sequencing (NGS) for patients with chondrosarcoma. CTOS Annual Meeting, 2017. e-Pub 2017.
27. Livingston JA, Tsai J, Advani S, Daw N, Lazar A, Conley AP, Wang WL. Expression and clinical correlations of PRAME in osteosarcoma. Connective Tissue Oncology Society Annual Meeting, 2016. e-Pub 2016.
28. Livingston JA, Wagner M, et al BR. Tailored post-operative therapy in adult osteosarcoma improves outcomes in patients with poor necrosis: 30 years of treatment at MD Anderson. Connective Tissue Oncology Society Annual Meeting, 2015. e-Pub 2015.
29. Wagner M, Livingston JA, Benjamin RS, al E. Vincristine, doxorubicin, and ifosfamide for the initial treatment of Ewing’s sarcoma in adults. Connective Tissue Oncology Society Annual Meeting, 2015. e-Pub 2015.
30. Livingston JA, Ofarrill-Santiago J, Gordon N, Kleinerman ES. Heat shock protein 27 (HSP27) as a predictor of autophagic fate in chemotherapy-induced autophagy in osteosarcoma. Connective Tissue Oncology Society Annual Meeting, 2015. e-Pub 2015.
31. Livingston JA, Somaiah N, al E. Assessing chemotherapy benefit in well-differentiated and de-differentiated retroperitoneal liposarcoma. Connective Tissue Oncology Society Annual Meeting, 2014. e-Pub 2014.
32. Gomes D, Livingston JA, et al SN. Defining the chemotherapy (CT) response in well-differentiated (WD) and dedifferentiated (DD) liposarcomas (LPS) of the retroperitoneum (RP): a tertiary referral cancer center experience. ASCO Annual Meeting, 2014. e-Pub 2014.
33. Livingston JA, V Subbiah V, al E. Eliciting early-response signals from first-in-human clinical trials and validation of prognostic scores in aggressive biology bone cancers: The MD Anderson experience. ASCO Annual Meeting 2014, 2014. e-Pub 2014.
34. Bupathi M, Livingston JA, et al SV. Clinical Next Generation Sequencing of Adolescents and Young Adult (AYA) patients with Cancer Reveals Aggressive Biology: A Preliminary Report. AACR Annual Meeting 2014, 2014. e-Pub 2014.
35. Sharma S, Livingston JA, Hatch S. Higher pelvic/para-aortic lymph node metastasis probability in cervical cancer patients with unexplained leukocytosis: a retrospective review. Western Association of Gynecologic Oncologists Annual Meeting 2014, 2014. e-Pub 2014.
36. Livingston JA, Dave S, Rao AV. Evaluating oncogenic pathway dysregulation in adolescents and young adults with acute myeloid leukemia. ASCO Annual Meeting, 2013. e-Pub 2013.

Book Chapters

1. Livingston JA, Ravi V, Ratan R, Patel S. Soft Tissue and Bone Sarcoma. In: The MD Anderson Manual of Medical Oncology, 2022.
2. Chin M, Livingston JA. Osteosarcoma. In: Sarcomas: Evidence-Based Diagnosis and Management. Springer, 2020.
3. Wu CC, Livingston JA. Genomics and the Immune Landscape of Osteosarcoma. In: Adv Exp Med Biol. Springer, 21-36, 2020.
4. Livingston JA, Conley AP, Ravi V, Patel S. Soft-Tissue and Bone Sarcomas. In: The MD Anderson Manual of Medical Oncology. 3rd. McGraw Hill Medical, 2016.